Back to Trades
Sell4
Emergent BioSolutions Inc.
EBS
Total Value
$205.9K
Net $115.6K sold
Sales
$115.6K
2 transactions
Company Information
- Company Name
- Emergent BioSolutions Inc.
- Ticker Symbol
- EBS
- CIK
- 0001367644
Insider Information
- Role
- Director
- Location
- GAITHERSBURG, MD
Director
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- Apr 30, 2026
- Accession Number
- 0001536908-26-000004
- Form Type
- 4
- Net Trading Amount
- -$115.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | 25,344 | — | Grant/Award | — |
| May 1, 2026 | Common Stock | 12,781 | $8.36 | Sale | $106.8K |
| May 1, 2026 | Common Stock | 980 | $8.94 | Sale | $8.8K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 30, 2026 | Derivative | 11,296 | $7.99 | Grant/Award | $90.3K |
Footnotes
- (F1)Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
- (F2)Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 8, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026.
- (F3)The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.70 to $8.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- (F4)The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.70 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- (F5)Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
- (F6)The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant.